MINISPEC MQ SERIES Contrast Agent Analyzer

A TD-NMR instrument that has long been used for Research & Development and Quality Control of MRI Contrast Agents.

The minispec is used to characterize and validate relaxation properties of pharmaceuticals known as “contrast agents” for MRI (Magnetic Resonance Imaging).

TD-NMR Contrast Agent Analysis

The minispec Contrast Agent Analyzer is used to study the effect of pharmaceuticals known as “MRI contrast agents” on the NMR relaxation of protons in water or fat. Contrast agents are used to enhance contrast in Magnetic Resonance images between tissues that otherwise would be difficult to differentiate. These are especially soft tissue of the central nervous, digestive, lymphatic and cardiovascular system, liver, breast and lung.
Design of a successful contrast agent requires conflicting pharmaceutical and MRI properties to be met at once: although metal ions like Mn^{2+} and Gd^{3+} may lead to a very good contrast enhancement, they need to be chelated because the applied concentrations of the ‘naked ions‘ are toxic.
The minispec mq-series of bench-top NMR instruments play a key role in characterizing and validating the properties of contrast agents. The task is to examine the T_1 and T_2 relaxation time shortening of fat and water protons by contrast agents. The fat and water protons are predominantly responsible for the MR image.

Features

Contrast Agent Analyzers:

mq60 - for relaxation time analyses near the field of a 1.5 T Clinical MRI system
mq20 - for relaxation time analyses near the field of a 0.5 T Clinical MRI system
mq7.5 - for measurement of relaxation time parameters at 0.17 T

Benefits

Win expensive MRI time
Operates all common pulse sequences for T1, T2 relaxation time analysis, at a touch of a button
Easy siting, benchtop
Cryogen free permanent magnet
Simple sample handling and measurement
Attractive price compared to MRI systems
Only small amount of expensive contrast agent required
21 CFR part 11 – compliant minispecPlus software is available
IQ/OQ qualification of delivered instrument by trained Bruker service personnel

Specifications

Console with Broadband RF Electronics:

Measuring frequency: 2 to 65 MHz
Modulator: 0°, 90°, 180°, and 270° RF phase channels
Transmitter: maximum power 300 W, linear power attenuation
Receiver: digital phase sensitive detection via quadrature receiver; analogue and digital filters
Pulse Programmer: resolution 20 nsec; Digitizer: 12-bit, 32K points per acquisition

Magnet Unit:

Fields available: 0.17 T, 0.47 T and 1.41 T

Probe Temperature Options

Fixed Temperature: Sample chamber temperature is regulated by magnet heating system at a temperature fixed between 35 and 45 °C
Variable Sample Temperature, + 5 to + 50 °C (mq60), - 5 to + 65 °C (mq20) Information about a broader temperature range on request

System Requirements